Journal article
New Antithrombotic Drugs American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Abstract
This chapter focuses on new antithrombotic drugs that are in phase II or III clinical testing. Development of these new agents was prompted by limitations of existing antiplatelet, anticoagulant, or fibrinolytic drugs. Addressing these unmet needs, this chapter (1) outlines the rationale for development of new antithrombotic agents, (2) describes the new antiplatelet, anticoagulant, and fibrinolytic drugs, and (3) provides clinical perspectives …
Authors
Weitz JI; Hirsh J; Samama MM
Journal
Chest, Vol. 133, No. 6, pp. 234s–256s
Publisher
Elsevier
Publication Date
June 2008
DOI
10.1378/chest.08-0673
ISSN
0012-3692